methoxyhydroxyphenylglycol has been researched along with Dystonia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shapiro, K; Sharpless, NS; Thal, LJ; Waltz, JM; Wolfson, LI | 1 |
| Brashear, A; Butler, IJ; Dobyns, WB; Farlow, MR; Kasarskis, EJ | 1 |
| Brashear, A; Butler, IJ; Dobyns, WB; Farlow, MR; Hyland, K | 1 |
| Balottin, U; Borgatti, R; Lanzi, G; Zambrino, CA | 1 |
| Sharpless, NS; Thal, LJ; Wolfson, LI | 1 |
| Hashimoto, T; Maekawa, N; Oishi, T; Sasaki, M; Tsuji, S | 1 |
| Barchas, JD; Berger, PA; Faull, KF; Stahl, SM | 1 |
| Beales, M; Lorden, JF; McKeon, TW; Oltmans, GA | 1 |
8 other study(ies) available for methoxyhydroxyphenylglycol and Dystonia
| Article | Year |
|---|---|
Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia.
Topics: Adolescent; Adult; Cerebral Ventricles; Child; Child, Preschool; Dystonia; Female; Glycols; Humans; Hydrocephalus; Male; Methoxyhydroxyphenylglycol; Movement Disorders; Norepinephrine | 1983 |
Variable phenotype of rapid-onset dystonia-parkinsonism.
Topics: Adolescent; Adult; Dopamine; Dystonia; Female; Follow-Up Studies; Genetic Carrier Screening; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurologic Examination; Parkinson Disease; Pedigree; Phenotype | 1996 |
Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Biomarkers; Deglutition Disorders; Dopamine; Dysarthria; Dystonia; Female; Genetic Carrier Screening; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Parkinson Disease; Pedigree; Serotonin; Time Factors | 1998 |
Consideration on two cases of dystonia-parkinsonism.
Topics: Carbidopa; Child; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary | 1991 |
Diminished levels of ventricular fluid norepinephrine metabolite and somatostatin in childhood-onset dystonia.
Topics: Adolescent; Adult; Age Factors; Cerebral Palsy; Child; Child, Preschool; Dystonia; Homovanillic Acid; Humans; Hydrocephalus; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Multiple Sclerosis; Norepinephrine; Parkinson Disease; Somatostatin | 1988 |
[A study on catecholamine metabolites in CSF in a patient with progressive dystonia with marked diurnal fluctuation].
Topics: Adolescent; Catecholamines; Circadian Rhythm; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol | 1988 |
CSF monamine metabolites in movement disorders and normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Phenylacetates | 1985 |
Alterations in the noradrenergic projection to the cerebellum of the dystonic (dt) rat.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Cerebellum; Dystonia; Female; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Norepinephrine; Rats; Rats, Inbred Strains; Rats, Mutant Strains; Receptors, Adrenergic, beta; Reserpine | 1986 |